Related Experiment Video
Updated: Sep 22, 2025

Author Spotlight: Studying the Epithelial Effects of Intestinal Inflammation In Vitro on Established Murine Colonoids
Published on: June 2, 2023
Pediatric Inflammatory Bowel Disease: A Multicenter Study of Changing Trends in Argentina Over the Past 30 Years
Maria Soledad Arcucci1, Monica Beatriz Contreras2, Julieta Gallo1
1Pediatric Gastroenterology, Hepatology and Liver Intestinal Transplantation Unit, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Insights
Pediatric inflammatory bowel disease (IBD) in Argentina shows a rising trend in Crohn's disease (CD) and a decrease in ulcerative colitis (UC) over 30 years. Surgical treatments declined with the introduction of biological therapies.
Area of Science:
- Gastroenterology
- Pediatrics
- Epidemiology
Background:
- Pediatric inflammatory bowel disease (IBD) encompasses chronic conditions like ulcerative colitis (UC) and Crohn's disease (CD).
- Understanding long-term trends in pediatric IBD is crucial for public health and clinical management.
Purpose of the Study:
- To analyze the 30-year characteristics of pediatric IBD in Argentina.
- To identify changes in IBD demographics and treatment between 1987-2007 and 2008-2017.
Main Methods:
- Retrospective, multicenter study of 756 children (0-18 years) diagnosed between 1987-2017.
- Data collected included clinical, endoscopic, histologic, and imaging findings, along with therapeutic strategies.
- Patients were grouped into two cohorts: 1987-2007 and 2008-2017.
Main Results:
- Ulcerative colitis (UC) affected 54%, Crohn's disease (CD) 33%, and IBD-unclassified (IBD-U) 13% of patients.
- An increasing incidence of CD and a decreasing incidence of UC/IBD-U were observed in the last decade.
- A 50% reduction in surgeries coincided with the introduction of biological therapies.
Conclusions:
- This is the first multicenter cohort study on pediatric IBD in Latin America over three decades.
- While CD incidence increased, UC remains prevalent in Argentina.
- Shifting treatment paradigms reflect the impact of advanced therapies.
Purpose:
To analyze the characteristics of pediatric inflammatory bowel disease (IBD) over the past three decades in Argentina and determine if there are differences between the first two decades and the past decade.
Methods:
We conducted a retrospective multicenter analytical study in children with IBD between 0 and 18 years of age diagnosed between 1987 and 2017 in three tertiary health centers in Argentina. The evaluation included clinical characterization, endoscopy, histology, and imaging data together with therapeutic strategies. The patients were divided into two groups: Group 1, diagnosed between 1987 and 2007, and Group 2, diagnosed between 2008 and 2017.
Results:
Of the 756 patients included, 409 (54%) had ulcerative colitis (UC), 250 (33%) had Crohn's disease (CD), and 97 (13%) had IBD-unclassified (IBD-U). The positive family history was 3.8%, which was more frequent among children under two years of age (6.7%). There were no significant differences in clinical presentation and extraintestinal manifestations between periods, with hepatic manifestations being the most frequent. In the last decade, we found an upward trend in CD, a downward trend in UC/IBD-U, even after adjustment for socioeconomic status, and a decrease of 50% in surgical treatments coinciding with the advent of biological therapy.
Conclusion:
This is the first multicenter cohort study in a Latin American country to describe clinical, endoscopic, and therapeutic data across the past 30-year period. Although CD was responsible for the overall increase in incidence, UC was still prevalent in this region.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:

